| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.061 | 0.1 |